Novel ferroportin inhibitors

The invention relates to novel compounds of the general formula (A-I), with Het-2 being an optionally substituted bicyclic heteroaryl of the formula (AA) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the use as ferroportin inhibitors, more particul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pena, Paula, Dürrenberger, Franz, Shepherd, Jon, Scott, John, Burgert, Michael, Manolova, Vania, Boyce, Susan, Yarnold, Christopher John, Kalogerakis, Aris, Burckhardt, Susanna, Lecci, Cristina, Buhr, Wilm, Jarjes-Pike, Richard, Reim, Stefan
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Pena, Paula
Dürrenberger, Franz
Shepherd, Jon
Scott, John
Burgert, Michael
Manolova, Vania
Boyce, Susan
Yarnold, Christopher John
Kalogerakis, Aris
Burckhardt, Susanna
Lecci, Cristina
Buhr, Wilm
Jarjes-Pike, Richard
Reim, Stefan
description The invention relates to novel compounds of the general formula (A-I), with Het-2 being an optionally substituted bicyclic heteroaryl of the formula (AA) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the use as ferroportin inhibitors, more particularly for the use in the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ740675A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ740675A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ740675A3</originalsourceid><addsrcrecordid>eNrjZJDxyy9LzVFISy0qyi_ILyrJzFPIzMvITMosyS8q5mFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8X5R5iYGZuamjsYEFQAAB-kjPg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel ferroportin inhibitors</title><source>esp@cenet</source><creator>Pena, Paula ; Dürrenberger, Franz ; Shepherd, Jon ; Scott, John ; Burgert, Michael ; Manolova, Vania ; Boyce, Susan ; Yarnold, Christopher John ; Kalogerakis, Aris ; Burckhardt, Susanna ; Lecci, Cristina ; Buhr, Wilm ; Jarjes-Pike, Richard ; Reim, Stefan</creator><creatorcontrib>Pena, Paula ; Dürrenberger, Franz ; Shepherd, Jon ; Scott, John ; Burgert, Michael ; Manolova, Vania ; Boyce, Susan ; Yarnold, Christopher John ; Kalogerakis, Aris ; Burckhardt, Susanna ; Lecci, Cristina ; Buhr, Wilm ; Jarjes-Pike, Richard ; Reim, Stefan</creatorcontrib><description>The invention relates to novel compounds of the general formula (A-I), with Het-2 being an optionally substituted bicyclic heteroaryl of the formula (AA) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the use as ferroportin inhibitors, more particularly for the use in the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240223&amp;DB=EPODOC&amp;CC=NZ&amp;NR=740675A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240223&amp;DB=EPODOC&amp;CC=NZ&amp;NR=740675A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Pena, Paula</creatorcontrib><creatorcontrib>Dürrenberger, Franz</creatorcontrib><creatorcontrib>Shepherd, Jon</creatorcontrib><creatorcontrib>Scott, John</creatorcontrib><creatorcontrib>Burgert, Michael</creatorcontrib><creatorcontrib>Manolova, Vania</creatorcontrib><creatorcontrib>Boyce, Susan</creatorcontrib><creatorcontrib>Yarnold, Christopher John</creatorcontrib><creatorcontrib>Kalogerakis, Aris</creatorcontrib><creatorcontrib>Burckhardt, Susanna</creatorcontrib><creatorcontrib>Lecci, Cristina</creatorcontrib><creatorcontrib>Buhr, Wilm</creatorcontrib><creatorcontrib>Jarjes-Pike, Richard</creatorcontrib><creatorcontrib>Reim, Stefan</creatorcontrib><title>Novel ferroportin inhibitors</title><description>The invention relates to novel compounds of the general formula (A-I), with Het-2 being an optionally substituted bicyclic heteroaryl of the formula (AA) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the use as ferroportin inhibitors, more particularly for the use in the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDxyy9LzVFISy0qyi_ILyrJzFPIzMvITMosyS8q5mFgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8X5R5iYGZuamjsYEFQAAB-kjPg</recordid><startdate>20240223</startdate><enddate>20240223</enddate><creator>Pena, Paula</creator><creator>Dürrenberger, Franz</creator><creator>Shepherd, Jon</creator><creator>Scott, John</creator><creator>Burgert, Michael</creator><creator>Manolova, Vania</creator><creator>Boyce, Susan</creator><creator>Yarnold, Christopher John</creator><creator>Kalogerakis, Aris</creator><creator>Burckhardt, Susanna</creator><creator>Lecci, Cristina</creator><creator>Buhr, Wilm</creator><creator>Jarjes-Pike, Richard</creator><creator>Reim, Stefan</creator><scope>EVB</scope></search><sort><creationdate>20240223</creationdate><title>Novel ferroportin inhibitors</title><author>Pena, Paula ; Dürrenberger, Franz ; Shepherd, Jon ; Scott, John ; Burgert, Michael ; Manolova, Vania ; Boyce, Susan ; Yarnold, Christopher John ; Kalogerakis, Aris ; Burckhardt, Susanna ; Lecci, Cristina ; Buhr, Wilm ; Jarjes-Pike, Richard ; Reim, Stefan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ740675A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Pena, Paula</creatorcontrib><creatorcontrib>Dürrenberger, Franz</creatorcontrib><creatorcontrib>Shepherd, Jon</creatorcontrib><creatorcontrib>Scott, John</creatorcontrib><creatorcontrib>Burgert, Michael</creatorcontrib><creatorcontrib>Manolova, Vania</creatorcontrib><creatorcontrib>Boyce, Susan</creatorcontrib><creatorcontrib>Yarnold, Christopher John</creatorcontrib><creatorcontrib>Kalogerakis, Aris</creatorcontrib><creatorcontrib>Burckhardt, Susanna</creatorcontrib><creatorcontrib>Lecci, Cristina</creatorcontrib><creatorcontrib>Buhr, Wilm</creatorcontrib><creatorcontrib>Jarjes-Pike, Richard</creatorcontrib><creatorcontrib>Reim, Stefan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Pena, Paula</au><au>Dürrenberger, Franz</au><au>Shepherd, Jon</au><au>Scott, John</au><au>Burgert, Michael</au><au>Manolova, Vania</au><au>Boyce, Susan</au><au>Yarnold, Christopher John</au><au>Kalogerakis, Aris</au><au>Burckhardt, Susanna</au><au>Lecci, Cristina</au><au>Buhr, Wilm</au><au>Jarjes-Pike, Richard</au><au>Reim, Stefan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel ferroportin inhibitors</title><date>2024-02-23</date><risdate>2024</risdate><abstract>The invention relates to novel compounds of the general formula (A-I), with Het-2 being an optionally substituted bicyclic heteroaryl of the formula (AA) pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the use as ferroportin inhibitors, more particularly for the use in the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia and hemochromatosis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_NZ740675A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Novel ferroportin inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T13%3A54%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Pena,%20Paula&rft.date=2024-02-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ740675A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true